Pharmacokinetic interaction between ivabradine and ciprofloxacine in healthy volunteers

Studia Universitatis Babes-Bolyai Chemia

Volumn 3, Issue , 2009, Pages 264-271

  Vlase, Laurian ^a   Muntean, Dana ^a,b   Popa, Adina ^a   Neag, Maria ^a   Bâldea, Ioan ^b   Achim, Marcela ^a   Leucuţa, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Ciprofloxacin; Drug interaction; Ivabradine; Pharmacokinetics

Indexed keywords

EID: 70350398753     PISSN: 12247154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. U.K. Prasad, D. Gray, H. Purcell, Advances In Therapy, 2009, 26(2), 127.
2. M.Z. Khawaja, D.M. Walker, International Journal Of Clinical Practice, 2009, 63(4), 542
3. J. C. Tardif, P. Ponikowski, T. Kahan, European Heart Journal, 2009, 30(5), 540
4. P. Milliez, S. Messaoudi, J. Nehme, C. Rodriguez, J. L. Samuel, C. Delcayre, American Journal Of Physiology-Heart And Circulatory Physiology, 2009, 296(2), H435
5. G. Riccioni, N. Vitulano, N. D'Orazio, Advances In Therapy, 2009, 26(1), 12
6. A. Portoles, A. Calvo, A. Terleira, L. Laredo, G. Resplandy, C. Gorostiaga, A. Moreno, Journal of Clinical Pharmacology, 2006, 46, 1195.
7. A. Portoles, A. Terleira, A. Calvo, Journal Of Clinical Pharmacology, 2006, 46(10), 1188
8. A. Portoles, A. Calvo, A. Terleira, L. Laredo, G. Resplandy, G. Gorostiaga, A. Moreno, Journal Of Clinical Pharmacology, 2006, 46(10), 1195
9. Z. Iqbal, A. Khan, A. Naz, J. A. Khan, G. S. Khan, Clinical Drug Investigation, 2009, 29(4), 275
10. H. S. Abou-Auda, A. A. Mustafa, M. S. Al-Humayyd, Biopharmaceutics & Drug Disposition, 2008, 29(1), 29
11. K. Herrlin, M. Segerdahl, L. L. Gustafsson, E. Kalso, Lancet, 2000 356(9247), 2069.
12. L. Vlase, D. Muntean, S. E. Leucuta, I. Baldea, Studia Universitatis Babes-Bolyai Chemia, 2009, 54(2), 43
13. http://www.thermo.com/eThermo/CMA/PDFs/Product/productPDF_27347.pdf
14. D. J. Schuirmann, J Pharmacokinet Biopharm 1987, 15(6), 657
15. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administrated Drug Products - General Considerations, Rockville, USA, 2003, http://www.fda.gov/cder/guidance/index.htm
16. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, London, UK, 2001 (CPMP/EWP/QWP/1401/98).
17. L. Vlase, A. Leucuta, D. Farcau D, M. Nanulescu, Biopharmaceutics & Drug Disposition, 2006, 27(6), 285
18. L. Vlase, B. Bodiu B, S.E. Leucuta, Arzneimittel-Forschung-Drug Research, 2005, 55(11), 664